[Effectiveness of CLAT Protocol for Treating Patients with Refractory Acute Myeloid Leukemia].


OBJECTIVE To explore the clinical efficacy and toxicity of CLAT protocol (cladribine, cytarabine and topotecan) for treating patients with refractory acute myeloid leukemia (R-AML). METHODS A total of 18 patients with R-AML (median age 37 years, range 18 to 58 years; male n = 16, female n = 2) were treated with CLAT protocol, which consisted of cladribine… (More)
DOI: 10.7534/j.issn.1009-2137.2016.02.017


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics